GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (FRA:E8M) » Definitions » Valuation Rank

Elixinol Wellness (FRA:E8M) Valuation Rank


View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Elixinol Wellness Valuation Rank Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixinol Wellness Business Description

Traded in Other Exchanges
Address
100 Albert Road, South Melbourne, Melbourne, VIC, AUS, 2000
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.